Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated Laser Therapies (ILT) is a medical technology and clinical services company specializing in High Intensity Laser Therapy (HILT) for pain management and tissue regeneration. The company was a pioneer in the development of Class IV laser systems designed for photobiomodulation, a process that uses specific wavelengths of light to stimulate cellular repair and reduce inflammation. While its core manufacturing and technology assets were acquired by LiteCure (now part of Enovis) in 2006, the company continues to operate as a clinical provider and distributor of advanced laser therapy solutions. ILT's technology specifically targets cytochrome c oxidase in the mitochondria to enhance ATP production, providing a non-invasive alternative for treating musculoskeletal conditions and chronic pain in both human and veterinary medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrated Laser Therapies.